Connect with us
European Gaming Congress 2024

Fintech PR

ESG Book partners with the Sustainable Finance Institute Asia for pilot initiative on ESG data disclosure

Published

on

esg-book-partners-with-the-sustainable-finance-institute-asia-for-pilot-initiative-on-esg-data-disclosure

SFIA identifies ESG Book as a potential technology partner for Project SAFE, an initiative to address ESG data requirements and disclosure gaps in ASEAN markets. 

  • The Single Accesspoint for ESG Data (SAFE) Initiative brings together industry stakeholders to support sustainable finance across ASEAN markets through accessible, comparable, and transparent ESG data.
  • As the world’s largest sustainability disclosure platform, ESG Book’s real-time, cloud-native technology directly connects corporates with financial institutions.
  • Built on Google Cloud infrastructure, ESG Book’s platform hosts over 10,000 users globally, and enables companies to disclose ESG data to stakeholders in a digitised, secure, and centralised way.

LONDON and SINGAPORE, Aug. 30, 2023 /PRNewswire/ — London and Singapore – ESG Book, a global leader in sustainability data and technology, has partnered with the Sustainable Finance Institute Asia (SFIA) for a pilot Initiative to address ESG data requirements and disclosure gaps in ASEAN markets, it has been announced.

Recognising the capabilities of ESG Book, SFIA has identified ESG Book as one of its potential technology partners for the Single Accesspoint for ESG Data (SAFE) Initiative, which brings together key industry stakeholders to enable sustainable finance across ASEAN markets through accessible, comparable, and transparent ESG data.

Advertisement
Stake.com

With financial institutions increasingly required to collect sustainability-related data from corporations to meet growing regulatory demands, the SAFE Initiative has been launched to help address data and disclosure gaps by providing credible, comprehensive, and consistent information for better and more informed ESG decision-making.

Leading financial organisations across ASEAN are invited to participate in the scheme, which is being supported by ESG Book’s market-leading technology.

As the world’s largest sustainability disclosure platform, ESG Book’s real-time, cloud-native technology directly connects corporates with financial institutions.

Built on Google Cloud infrastructure, ESG Book’s platform hosts over 10,000 users globally, and enables companies to disclose ESG data directly to stakeholders in a digitised, secure, and centralised way.

With an agile data model based on the latest industry requirements, ESG Book’s SaaS-based solution enables SAFE participants to benefit from: 

Advertisement
Stake.com
  • Seamless, intuitive, and digitised disclosure workflows.
  • Full ESG data ownership, control, and privacy with permissions functionalities.
  • The ability to disclose once and share publicly or privately with multiple financial institutions, materially reducing a company’s reporting burden.
  • Pre-populated disclosure ESG data based on publicly available information.
  • Continuous compatibility with the leading global disclosure requirements, including the International Sustainability Standards Board (ISSB) standards.

Dr Daniel Klier, CEO of ESG Book, said: “We are delighted that ESG Book is partnering with SFIA on its SAFE pilot Initiative to help address current ESG data requirements and disclosure gaps in ASEAN markets. With our mission to power financial markets for a sustainable future through accessible, comparable, and transparent data, we are fully aligned with the SFIA’s vision to help shape the future of ESG data through a collaborative approach.”

“Through this vital initiative, we look forward to delivering our next generation ESG technology solutions for SAFE pilot participants, and working with the SFIA to enhance the ESG data landscape across ASEAN markets.”

With 150,000 disclosures, ESG Book’s platform provides pre-populated data and analytics on public securities, as well as the ability to directly request ESG disclosures from private companies, combining public market ESG information with privately collected data.

The company serves over 100 institutional clients globally including Bloomberg, BNY Mellon, Citi, Dow Jones, Goldman Sachs, JP Morgan, HSBC, and Nasdaq.

ENDS

To learn more about the SAFE Initiative and to register interest to participate, visit: https://www.sfinstitute.asia/safe/

Advertisement
Stake.com

Notes to Editors

For more information and for all media requests, please contact Ciaran McCale, Head of Communication, ESG Book, at [email protected] or on +44 (0)7956 175 100.

About ESG Book

ESG Book is a global leader in sustainability data and technology, with a mission to transform finance through sustainability by making ESG data accessible, comparable, and transparent. ESG Book is the only provider in the world to combine a highly competitive, global sustainability dataset reported by corporates together with a disclosure platform. ESG Book’s solutions are used by many of the world’s largest financial organisations including Bloomberg, BNY Mellon, Citi, Dow Jones, JP Morgan, HSBC, and Glass Lewis.

Covering over 50,000 companies, ESG Book’s product offering includes ESG and climate data, company-level and portfolio-level scores, and analytics tools. ESG Book’s SaaS data management and disclosure platform provides access to over 150,000 corporate disclosures, enabling companies to disclose to stakeholders in real-time against multiple frameworks. For more information, visit esgbook.com.

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2196877/ESG_Book.jpg
Logo – https://mma.prnewswire.com/media/1825453/ESG_Book_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/esg-book-partners-with-the-sustainable-finance-institute-asia-for-pilot-initiative-on-esg-data-disclosure-301913654.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

Advertisement
Stake.com

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

Advertisement
Stake.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

Advertisement
Stake.com

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

Advertisement
Stake.com

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Advertisement
Stake.com
Continue Reading

Trending